SABS: SAB Biotherapeutics Company Short-Term Debt
SAB Biotherapeutics faces risks due to the high cost of biologic production and potential FDA rejection. Monitoring of current debt demonstrates liability dynamics, where the 0.00 level records fresh values. SAB Biotherapeutics seeks to validate its Type 1 diabetes therapy platform to secure partnerships, yet geopolitical tensions and sanctions seriously hinder the cross-border logistics of biomaterials and the execution of global trials.
Metric breakdowns and analytics for SAB Biotherapeutics Inc (SABS)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital SAB Biotherapeutics|SABS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity SAB Biotherapeutics|SABS - Company Total Debt|Debt to Book Capitalization Ratio SAB Biotherapeutics, Inc.|SABS - Company Long-Term Liabilities|Company Current Liabilities SAB Biotherapeutics|Quick Liquidity sabbiotherapeutics.com
- net income and valuation multiples indicators:
Initial company analysis:SABS - SAB Biotherapeutics, Inc.
Finding a balance between operational risks and return on equity requires an analysis of the liquidity of SAB Biotherapeutics (SABS), whose ability to rapidly develop viral antibodies provides a competitive pricing power advantage. The current volume of short-term loans aggregates all obligations with a maturity of up to one year, allowing for an assessment of the company's ability to service its debt without compromising the development of innovative drugs or overall financial stability.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB - Company Short-Term Debt|Short-Term Debt Volume Zenas Corp ZBIO|IMNM: Company Short-Term Debts|gossamerbio.com (GOSS) - Company Short-Term Debts|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Short-Term Debt SEPN|Company Current Liabilities PVLA (Pieris Pharmaceuticals Inc)|SVRA (Savara Pharma) - Company Short-Term Loans and Borrowings|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|anaptysbio.com - Company Short-Term Debt|Astria Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume enGene Holdings Inc ENGN|RAPT Therapeutics (RAPT) - Company Short-Term Debt|Short-Term Debt Aerovate Therapeutics (JBIO)|Company Current Liabilities ACRS|KYTX (kyvernatx.com) - Amount of Current Liabilities|Company Short-Term Debts TLSA|CABA (Cabaletta Bio Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts VTYX (Ventyx Bio)|Theratechnologies, Inc (THTX) - Short-Term Debt|AVTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings ELDN (eledon.com)|AGEN: Company Short-Term Debts|Climb Bio Inc. (CLYM) - Company Short-Term Debts|Company Short-Term Debt Zura Bio|aTyr Pharmaceuticals - Current Liabilities|Company Short-Term Debts ADAG|IMA - Short-Term Debt|Shattuck Labs - Company Current Liabilities|Company Short-Term Debts Equillium Inc EQ|CNTB: Company Current Liabilities|Immunic, Inc. - Amount of Current Liabilities|ATRA: Company Short-Term Debts|IFRX - Short-Term Debt Volume|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Current Liabilities Adicet (ACET)|Company Short-Term Debt Celularity Inc. (CELU)|Short-Term Debt Volume INmune Bio Corporation|Company Short-Term Debt Barinthus Biotherapeutics BRNS|Short-Term Debt Volume kezarlifesciences.com (KZR)|Akari Therapeutics Plc - Company Short-Term Debts|ENLV - Company Short-Term Debts|QTTB: Company Short-Term Debts|GOVX (GeoVax Corp) - Company Short-Term Debt|Company Short-Term Debt Edesa Biotech, Inc.|ibioinc.com (IBIO) - Short-Term Debt Volume|Company Short-Term Debt Carisma Therapeutics (CARM)|XTLB: Current Liabilities|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Loans and Borrowings HCWB|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|GRI Bio Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt XORTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Company Current Liabilities|Company Short-Term Loans and Borrowings CALI|Affimed Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Allakos Inc. ALLK|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|Company Short-Term Debts Third Harmonic Bio Inc (THRD)